Olivier E. Pardo

3.5k total citations
47 papers, 2.5k citations indexed

About

Olivier E. Pardo is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Olivier E. Pardo has authored 47 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 12 papers in Cell Biology and 9 papers in Oncology. Recurrent topics in Olivier E. Pardo's work include PI3K/AKT/mTOR signaling in cancer (11 papers), Protein Kinase Regulation and GTPase Signaling (7 papers) and Endoplasmic Reticulum Stress and Disease (6 papers). Olivier E. Pardo is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (11 papers), Protein Kinase Regulation and GTPase Signaling (7 papers) and Endoplasmic Reticulum Stress and Disease (6 papers). Olivier E. Pardo collaborates with scholars based in United Kingdom, United States and Switzerland. Olivier E. Pardo's co-authors include Michael J. Seckl, Julian Downward, Romain Lara, Rajat Roy, Nicholas R. Lemoine, Patricia H. Warne, Alexandre Arcaro, Richard Poulsom, Ivan Gout and Francesco Mauri and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Olivier E. Pardo

43 papers receiving 2.5k citations

Peers

Countries citing papers authored by Olivier E. Pardo

Since Specialization

Citations

This map shows the geographic impact of Olivier E. Pardo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier E. Pardo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier E. Pardo more than expected).

Fields of papers citing papers by Olivier E. Pardo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier E. Pardo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier E. Pardo. The network helps show where Olivier E. Pardo may publish in the future.

Co-authorship network of co-authors of Olivier E. Pardo

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier E. Pardo. A scholar is included among the top collaborators of Olivier E. Pardo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier E. Pardo. Olivier E. Pardo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	DrugSynthMC: An Atom-Based Generation of Drug-like Molecules with Monte Carlo Search 2024 ·Journal of Chemical Information and Modeling ·(unknown), (unknown), Tristan Cazenave, Filippo Prischi, Olivier E. Pardo	0
2	Investigating the Regulation of Ribosomal Protein S6 Kinase 1 by CoAlation 2024 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Volodymyr G. Bdzhola, (unknown), Olivier E. Pardo, Michael J. Seckl, (unknown), Sew‐Yeu Peak‐Chew, Mark Skehel, Lalitha Guruprasad, Alexander Zhyvoloup, Ivan Gout, Valeriy Filonenko	2
3	Asymmetric Dimethylation of Ribosomal S6 Kinase 2 Regulates Its Cellular Localisation and Pro-Survival Function 2023 ·International Journal of Molecular Sciences ·Mahmoud Khalil, Heba Ismail, Ganna Panasyuk, (unknown), Valeriy Filonenko, Ivan Gout, Olivier E. Pardo	2
4	Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells 2023 ·Cell Death and Disease ·(unknown), Rajat K. Roy, (unknown), (unknown), Jennifer Doig, Lukáš Krásný, (unknown), Anne E. Willis, Marion MacFarlane, Paul H. Huang, Neil O. Carragher, Alison F. Munro, Daniel J. Murphy, Kirill Veselkov, Michael J. Seckl, Miriam F. Moffatt, William Cookson, Olivier E. Pardo	6
5	ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma 2022 ·Oncogene ·(unknown), (unknown), (unknown), Rajat Roy, Geoffrey J. Maher, (unknown), (unknown), (unknown), (unknown), Paul Ajuh, Neil S. Horowitz, Ross S. Berkowitz, Kevin M. Elias, Michael J. Seckl, Olivier E. Pardo	11
6	Mechanisms Underlying Chemoresistance of Choriocarcinoma Investigated with NMR-Based Metabonomics 2019 ·SHILAP Revista de lepidopterología ·(unknown), Congcong Zhang, (unknown), Olivier E. Pardo, Michael J. Seckl, Yulan Wang, Junfang Wu	1
7	Tumor growth suppression using a combination of taxol-based therapy and GSK3 inhibition in non-small cell lung cancer 2019 ·PLoS ONE ·Linda O′Flaherty, Steven D. Shnyder, Patricia A. Cooper, Stephen Cross, James G. Wakefield, Olivier E. Pardo, Michael J. Seckl, Jeremy M. Tavaré	20
8	Oncogene-Selective Sensitivity to Synchronous Cell Death following Modulation of the Amino Acid Nutrient Cystine 2017 ·Cell Reports ·(unknown), Xiaomeng Wang, (unknown), Christiaan F. Labuschagne, David Y. Mason, (unknown), Kendra Triplett, Rajat Roy, Olivier E. Pardo, Michael J. Seckl, Scott W. Rowlinson, Everett Stone, Richard F. Lamb	206
9	Decreased glutathione biosynthesis contributes to EGFR T790M-driven erlotinib resistance in non-small cell lung cancer 2016 ·Cell Discovery ·Hongde Li, (unknown), (unknown), Rajat Roy, Elza de Bruin, (unknown), Zhigang Liu, Egbert F. Smit, Guus J.J.E. Heynen, Julian Downward, Michael J. Seckl, Yulan Wang, Huiru Tang, Olivier E. Pardo	28
10	S6K2: The Neglected S6 Kinase Family Member 2013 ·Frontiers in Oncology ·Olivier E. Pardo, Michael J. Seckl	54
11	An siRNA screen identifies RSK1 as a key modulator of lung cancer metastasis 2011 ·Oncogene ·Romain Lara, Francesco Mauri, (unknown), Rita Derua, Alice Shia, Colin Gray, (unknown), Robert J. Shiner, (unknown), Paul A. Bates, Etienne Waelkens, Margaret J. Dallman, Jonathan R. Lamb, Daniel Zicha, Julian Downward, Michael J. Seckl, Olivier E. Pardo	78
12	The catalytic class IA PI3K isoforms play divergent roles in breast cancer cell migration 2010 ·Cellular Signalling ·Angela De Laurentiis, Olivier E. Pardo, Andrea Palamidessi, Shaun P. Jackson, Simone M. Schoenwaelder, Ernst Reichmann, Giorgio Scita, Alexandre Arcaro	6
13	The Fibroblast Growth Factor Receptor Inhibitor PD173074 Blocks Small Cell Lung Cancer Growth In vitro and In vivo 2009 ·Cancer Research ·Olivier E. Pardo, John Latigo, Rosemary Jeffery, Emma Nye, Richard Poulsom, Bradley Spencer‐Dene, Nicholas R. Lemoine, Gordon Stamp, Eric O. Aboagye, Michael J. Seckl	134
14	AKT/mTOR Pathway Activation and BCL-2 Family Proteins Modulate the Sensitivity of Human Small Cell Lung Cancer Cells to RAD001 2009 ·Clinical Cancer Research ·Marin Marinov, Algirdas Ziogas, Olivier E. Pardo, (unknown), Tony Dhillon, Francesco Mauri, Heidi A. Lane, Nicholas R. Lemoine, Uwe Zangemeister‐Wittke, Michael J. Seckl, Alexandre Arcaro	79
15	Yes-associated protein (YAP) functions as a tumor suppressor in breast 2008 ·Cell Death and Differentiation ·Ming Yuan, (unknown), Romain Lara, Deborah L. Holliday, Claude Chelala, Takeshi Harada, Rathi Gangeswaran, (unknown), Paul J. Smith, Safia Danovi, Olivier E. Pardo, Tim Crook, Charles A. Mein, Nicholas R. Lemoine, J. Louise Jones, Soumalee Basu	271
16	Regulators of Mitotic Arrest and Ceramide Metabolism Are Determinants of Sensitivity to Paclitaxel and Other Chemotherapeutic Drugs 2007 ·Cancer Cell ·Charles Swanton, Michela Marani, Olivier E. Pardo, Patricia H. Warne, Gavin Kelly, Erik Sahai, Frédéric Elustondo, Jenny C. Chang, Jillian Temple, Ahmed A. Ahmed, James D. Brenton, Julian Downward, Barbara Nicke	307
17	FGF‐2 protects small cell lung cancer cells from apoptosis through a complex involving PKCε, B‐Raf and S6K2 2006 ·The EMBO Journal ·Olivier E. Pardo, Claudia Wellbrock, (unknown), Muriel Aubert, Imanol Arozarena, (unknown), Frances Bowen, Peter J. Parker, Valeriy Filonenko, Ivan Gout, Neil J. Sebire, Richard Marais, Julian Downward, Michael J. Seckl	144
18	CUTL1 is a target of TGFβ signaling that enhances cancer cell motility and invasiveness 2005 ·Cancer Cell ·Patrick Michl, Antoine R. Ramjaun, Olivier E. Pardo, Patricia H. Warne, Martin Wagner, Richard Poulsom, Corrado D’Arrigo, K W Ryder, André Menke, Thomas M. Gress, Julian Downward	135
19	Novel cross talk between MEK and S6K2 in FGF-2 induced proliferation of SCLC cells 2001 ·Oncogene ·Olivier E. Pardo, Alexandre Arcaro, Giovanni Salerno, Teresa D. Tetley, Taras Valovka, Ivan Gout, Michael J. Seckl	64
20	Cancer Gene Therapy with a Heat Shock Protein Gene 1998 ·Advances in experimental medicine and biology ·Olivier E. Pardo, Julia Colston, Katalin Lukács	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact